Similar articles

• Hepatitis B virus kinetics and mathematical modeling.

  Perelson AS, Ribeiro RM. Perelson AS, et al. Semin Liver Dis. 2004;24 Suppl 1:11-6. doi: 10.1055/s-2004-828673. Semin Liver Dis. 2004. PMID: 15192796 Review.
• Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine.

  Manolakopoulos S, Bethanis S, Koutsounas S, Goulis J, Vlachogiannakos J, Christias E, Saveriadis A, Pavlidis C, Triantos C, Christidou A, Papatheodoridis G, Karamanolis D, Tzourmakliotis D. Manolakopoulos S, et al. Aliment Pharmacol Ther. 2008 Feb 1;27(3):266-73. doi: 10.1111/j.1365-2036.2007.03567.x. Epub 2007 Nov 5. Aliment Pharmacol Ther. 2008. PMID: 17988233
• Viral kinetics in patients with lamivudine-resistant hepatitis B during adefovir-lamivudine combination therapy.

  Mihm U, Gärtner BC, Faust D, Hofmann WP, Sarrazin C, Zeuzem S, Herrmann E. Mihm U, et al. J Hepatol. 2005 Aug;43(2):217-24. doi: 10.1016/j.jhep.2005.02.037. J Hepatol. 2005. PMID: 15964093
• [The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B].

  Lin Q, Zhang DZ. Lin Q, et al. Zhonghua Gan Zang Bing Za Zhi. 2009 Oct;17(10):722-5. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19874684 Chinese. No abstract available.
• [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].

  Benhamou Y. Benhamou Y. Gastroenterol Clin Biol. 2006 Oct;30(10 Pt 2):3S22-5. Gastroenterol Clin Biol. 2006. PMID: 17075492 Review. French. No abstract available.